Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543

Clinical trial NCT05467722 · COMPLETED

Trial details

NCT number: NCT05467722
Sponsor: Concert Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2022-06-01
Primary completion: 2022-09-15
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.